Japan· JP-6343456D1024

乾燥濃縮人α１－プロテイナーゼインヒビター

A medicinal product containing 乾燥濃縮人α１－プロテイナーゼインヒビター, registered in Japan by オーファンパシフィック, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about 乾燥濃縮人α１－プロテイナーゼインヒビターAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)

Active substance: 乾燥濃縮人α１－プロテイナーゼインヒビター
Manufacturer: オーファンパシフィック
Country: Japan (JP)
ATC code: —
Reimbursed: Yes
Source register: MHLW / PMDA (Japan)
Last checked: September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

乾燥濃縮人α１－プロテイナーゼインヒビター in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 乾燥濃縮人α１－プロテイナーゼインヒビター products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Austria · Prolastin
Belgium · Pulmolast
Cyprus · Prolastina
Czechia · Prolastina
Germany · Prolastin
Denmark · Prolastina
Spain · Prolasplan, Prolastina
Finland · Prolastina
France · Alfalastin, Prolastin
Greece · Prolastin
Croatia · Prolastina
Ireland · Prolastin
Iceland · Respreeza
Italy · Plitalfa, Prolastin
Liechtenstein · Respreeza
Netherlands · Prolastin
Norway · Prolastina, Respreeza
Poland · Prolastin, Prolastin, 4000 Mg
Portugal · Prolastin
Sweden · Prolastina
Slovakia · Prolastina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0f2f554e-1c9b-4a14-9e31-38d4b5cdbb61
GET /v1/drugs/0f2f554e-1c9b-4a14-9e31-38d4b5cdbb61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１，０００ｍｇ１瓶（溶解液付）",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6343456D1024",
  "category": "注射薬",
  "price_yen": 216054,
  "generic_name": "乾燥濃縮人α１－プロテイナーゼインヒビター",
  "product_name_jp": null,
  "therapeutic_class": "6343",
  "transitional_expiry": null
}

API reference MCP server Plans

See everything about 乾燥濃縮人α１－プロテイナーゼインヒビター.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console